Studies and
Clinical Trials

Are you curious about what research is happening now? Ever wondered if you could be part of a clinical trial? AHHA has set up this page to let you know what research is going on. Check out the following professionally run, holistic and integrative-related clinical trials and studies.


Title: Coconut Oil for Alzheimer’s Disease
Sponsor: University of South Florida
Medical Director: Amanda G. Smith, MD
Purpose: The goal of this randomized study is to determine the effect of taking coconut oil (Fuel For Thought™) on the cognition, functioning and behavior of older adults with mild to moderate Alzheimer’s disease.
Participant Requirements: Participants must be between 60 – 85 years old with a diagnosis of mild to moderate Alzheimer’s disease and be able to participate for a six month period.
Participant’s Receive: Participants will take Fuel For Thought™, a coconut oil fortified with medium-chain triglycerides, administered as 1.25-ounce drink, for either Months 1-3 or Months 4-6 of the study; a placebo will be taken during the other 3-month period.
Status: Currently recruiting participants.
For Further Information:

Title: Online genetic study of Inflammatory Bowel Disease (Crohn’s and Ulcerative Colitis)
Sponsor: 23andMe
Study Supervisor: Anna Faaborg
Purpose: Currently, the cause of IBD is unknown, but previous research suggests that there is a strong genetic component. The 23andMe web-based platform enables a large group of individuals with IBD to come together to provide valuable information for research, including genetic information (using DNA from saliva) and information about each participant’s unique experiences with the disease (using responses from online surveys).
Participant Requirements: Diagnosed with Crohn’s disease or ulcerative colitis by a physician. We will ask you to provide a DNA sample (extracted from your saliva) for genetic analysis. We will keep this saliva/DNA stored in our laboratory. We will also ask you to complete a number of online surveys about IBD. These could include questions about your diagnosis, treatment, symptoms, medications or family history.
Participant’s Receive: 23andMe Personal Genome Service at no cost, which provides information about your ancestry, and uninterpreted genetic data.
Status: Currently recruiting participants.
For Further Information:


Title: Lifelong feeding of cottonseed to female rats and Alzheimer’s
Sponsor: Wisconsin Institute of Nutrition Research Foundation
Study Supervision: Care Research in Colorado
Medical Director: Bruce Semon, MD, PhD
Purpose: The purpose of the study is to replicate preliminary results that long term feeding of small amounts of cottonseed cause Alzheimer’s Disease in female rats. Cottonseed, which contains toxic chemicals, is used in animal feed, and gets into the human food supply. This study is being repeated with more rats to replicate the results for publication.
Participant Requirements: This is an animal study. No human volunteers are needed.
Status: The study takes two to three years of feeding. The rats are entering their second year of eating the cottonseed.
For Further Information: and 262-643-4222

Title: Longevinex® Confirm Study 2014
Sponsor: Resvertrol Partners, LLC
Study Supervisor: Bill Sardi
Medical Director: Marc Rose, MD
Purpose: Designed to determine by blood sampling whether Longevinex®, an all-natural proprietary blend supplement with resveratrol, favorably modifies markers of aging in humans.
Participant Requirements: Open to men over age 40 and women over age 60. Participants have a blood sample drawn at a lab in Fountain Valley (Orange County), CA; faithfully take one Longevinex® capsule per day for six months; then have a second blood sample drawn at the lab in Fountain Valley, CA.
Participants Receive: A six-month supply of Longevinex® to take during the study, then another complimentary six-month supply of Longevinex® at completion of study as a thank you for participation. Also their personal blood test results.
Status: Recruitment closed for both Phase 1 and 2 – study in progress.
For Further Information:



Title:Trial to Assess Chelation Therapy
Sponsor: U.S. National Institutes of Health (National Heart, Lung, and Blood Institute/ National Center for Complementary and Alternative Medicine)
Study Supervision: Mount Sinai Medical Center, Miami Beach, FL
Medical Director: Gervasio Lamas, MD
Purpose: The major goal of the Trial to Assess Chelation Therapy is to determine whether an intensive course of disodium EDTA chelation, will reduce major adverse coronary events in patients with coronary artery disease who have recovered from a prior myocardial infarction. The primary endpoint of this trial was a composite of all cause mortality, myocardial infarction, stroke, coronary revascularization, and hospitalization for angina.
Participant Requirements: The study has completed enrollment
Participant’s Receive: Participants were randomly assigned to receive 40 infusions of either the standard disodium EDTA chelation solution or placebo.
Status: Research results have been published.
For Further Information:

Disclaimer: AHHA is not affiliated with any of these projects. The listings are presented here so that you can see what is being studied. This information is for informational purposes only.

Contact the AHHA office if you would like to apply for a free listing for your research information. There is a review process.
Send the following to…
Study Supervision:
Medical Director:
Purpose: [prefer 80 words or less]
Participant Requirements: [include duration]
Participant’s Receive:
Status: [include which category* your project is currently in]
For Further Information: [website or phone/email]
Liaison Person & Contact Information:
*Category Options…